Works matching IS 00282685 AND DT 2020 AND VI 67 AND IP 4

Results: 25

SOCS2 affects the proliferation, migration, and invasion of nasopharyngeal carcinoma cells via regulating EphA1.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 794, doi. 10.4149/neo_2020_190807N724

By:

DAI, B.;
ZHANG, X.

Publication type:

Article

Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance (MGUS): Single-center experience.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 939, doi. 10.4149/neo_2020_191104N1137

By:

SANDECKA, V.;
ADAM, Z.;
KREJCI, M.;
STORK, M.;
REHAK, Z.;
KOUKALOVA, R.;
SEVCIKOVA, S.;
BROZOVA, L.;
KRAL, Z.;
MAYER, J.;
POUR, L.

Publication type:

Article

The expression of CD73 on pathological B-cells is associated with shorter overall survival of patients with CLL.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 933, doi. 10.4149/neo_2020_190826N822

By:

KICOVA, M.;
MICHALOVA, Z.;
COMA, M.;
GABZDILOVA, J.;
DEDINSKA, K.;
GUMAN, T.;
BERNATOVA, S.;
HAJIKOVA, M.;
GIERTLOVA, M.;
VESELINYOVA, D.;
SARISSKY, M.

Publication type:

Article

Effects of sarcopenia, hypoalbuminemia, and laparoscopic surgery on postoperative complications in elderly patients with colorectal cancer: A prospective study.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 922, doi. 10.4149/neo_2020_190908N882

By:

CHEN, W. S.;
HUANG, Y. S.;
XU, L. B.;
SHI, M. M.;
CHEN, X. D.;
YE, G. Q.;
WU, T. T.;
ZHU, G. B.

Publication type:

Article

Hypomethylation of CTCFL promoters as a noninvasive biomarker in plasma from patients with hepatocellular carcinoma.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 909, doi. 10.4149/neo_2020_190819N789

By:

CHEN, M. M.;
ZHAO, R. C.;
CHEN, K. F.;
HUANG, Y.;
LIU, Z. J.;
WEI, Y. G.;
JIAN, Y.;
SUN, A. M.;
QIN, L.;
LI, B.;
QIN, Y.

Publication type:

Article

Study of DOK4 gene expression and promoter methylation in sporadic breast cancer.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 916, doi. 10.4149/neo_2020_190811N747

By:

HEIDARIZADI, A.;
SALIMI, M.;
MOZDARANI, H.

Publication type:

Article

Evaluation of an amplicon-based custom gene panel for the diagnosis of hereditary tumors.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 898, doi. 10.4149/neo_2020_190918N925

By:

SHINRIKI, S.;
MAESHIRO, M.;
SHIMAMURA, K.;
KAWASHIMA, J.;
ARAKI, E.;
IBUSUKI, M.;
YAMAMOTO, Y.;
IWASE, H.;
MIYAMOTO, Y.;
BABA, H.;
YAMAGUCHI, M.;
MATSUI, H.

Publication type:

Article

Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 889, doi. 10.4149/neo_2020_190814N758

By:

WEI, H.;
DONG, C.;
SHEN, Z.

Publication type:

Article

O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 880, doi. 10.4149/neo_2020_191006N1009

By:

JIN, L.;
LU, M. H.;
DAI, G. C.;
YAO, Q.;
XIANG, H.;
WANG, L. X.;
XUE, B. X.;
LIU, X. L.

Publication type:

Article

LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 871, doi. 10.4149/neo_2020_190826N821

By:

QIU, Z.;
PAN, X. X.;
YOU, D. Y.

Publication type:

Article

Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 861, doi. 10.4149/neo_2020_190808N731

By:

YUAN, J. H.;
LI, W. X.;
HU, C.;
ZHANG, B.

Publication type:

Article

Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 834, doi. 10.4149/neo_2020_190805N716

By:

JIAO, X. X.;
LIN, S. Y.;
LIAN, S. X.;
QIU, Y. R.;
LI, Z. H.;
CHEN, Z. H.;
LU, W. Q.;
ZHANG, Y.;
DENG, L.;
JIANG, Y.;
HU, G. H.

Publication type:

Article

The tumor suppressor NOR1 suppresses cell growth, invasiveness, and tumorigenicity in glioma.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 851, doi. 10.4149/neo_2020_190724N661

By:

CAI, J.;
LIU, C.;
YI, M.;
TAN, Y.;
CHEN, S.;
REN, N.;
CHENG, H.;
LI, X.;
XIONG, W.;
LI, G.;
WU, M.;
WANG, W.;
XIANG, B.

Publication type:

Article

Downregulation of nuclear protein-1 induces cell cycle arrest in G0/G1 phase in glioma cells in vivo and in vitro via P27.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 843, doi. 10.4149/neo_2020_190814N759

By:

LI, J.;
LIAN, Z. G.;
XU, Y. H.;
LIU, R. Y.;
WEI, Z. Q.;
LI, T.;
LV, H. T.;
ZHAO, Y. S.;
LIU, Y. J.;
DONG, B.;
FU, X.

Publication type:

Article

miR-193a-5p suppresses cell proliferation and induces cell apoptosis by regulating HOXA7 in human ovarian cancer.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 825, doi. 10.4149/neo_2020_190730N687

By:

WANG, S.;
DIAO, Y. J.;
ZHU, B. B.

Publication type:

Article

miR-33a-5p inhibits the growth and metastasis of melanoma cells by targeting SNAI2.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 813, doi. 10.4149/neo_2020_190823N811

By:

ZHANG, Z. R.;
YANG, N.

Publication type:

Article

The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 802, doi. 10.4149/neo_2020_190723N657

By:

WEI, C. M.;
ZHAO, X. F.;
QIU, H. B.;
MING, Z.;
LIU, K.;
YAN, J.

Publication type:

Article

Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 762, doi. 10.4149/neo_2020_190706N598

By:

ZHANG, L.;
WANG, Y.;
SU, H.

Publication type:

Article

LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 782, doi. 10.4149/neo_2020_190617N515

By:

XU, C.;
ZHAI, J.;
FU, Y.

Publication type:

Article

miR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 773, doi. 10.4149/neo_2020_190730N689

By:

YE, J.;
XIAO, X.;
HAN, Y.;
FAN, D.;
ZHU, Y.;
YANG, L.

Publication type:

Article

LncRNA TUG1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma by regulating XBP1 via competitively binding to miR-498.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 751, doi. 10.4149/neo_2020_190805N717

By:

JIN, G.;
YANG, Y.;
TUO, G.;
WANG, W.;
ZHU, Z.

Publication type:

Article

SKA2 promotes proliferation and invasion of hepatocellular carcinoma cells via activating the β-catenin signaling pathway.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 743, doi. 10.4149/neo_2020_190709N609

By:

WANG, D.;
SUO, Y. J.;
GONG, L.;
LV, S. Q.

Publication type:

Article

Regulation of HBV replication and gene expression by miR-501-3p via targeting ZEB2 in hepatocellular carcinoma.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 735, doi. 10.4149/neo_2020_190625N549

By:

ZHONG, Z. J.;
XU, J. F.;
LI, Z. Z.;
ZHOU, W. Y.;
CHEN, X. X.;
ZHOU, J. H.;
LI, Z. Y.

Publication type:

Article

miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 724, doi. 10.4149/neo_2020_190423N366

By:

GAO, S.;
WANG, K.;
WANG, X.

Publication type:

Article

Adverse events and management of apatinib in patients with advanced or metastatic cancers: A review.

Published in:

Neoplasma, 2020, v. 67, n. 4, p. 715, doi. 10.4149/neo_2020_190801N701

By:

SHAO, F.;
ZHANG, H.;
YANG, X.;
LUO, X.;
LIU, J.

Publication type:

Article